Details for Patent: 10,188,652
✉ Email this page to a colleague
Which drugs does patent 10,188,652 protect, and when does it expire?
Patent 10,188,652 protects DAYVIGO and is included in one NDA.
This patent has seventeen patent family members in thirteen countries.
Summary for Patent: 10,188,652
| Title: | Compositions and methods for treating insomnia |
| Abstract: | In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-- (5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses. |
| Inventor(s): | Moline; Margaret (Woodcliff Lake, NJ), Pastino; Gina (Woodcliff Lake, NJ), Akimoto; Yurie (Kakamigahara, JP), Zaima; Yasuhiro (Kakamigahara, JP), Suzuki; Nobuya (Kakamigahara, JP), Yoshida; Nobuo (Kakamigahara, JP) |
| Assignee: | Eisai R&D Management Co., Ltd. (Tokyo, JP) |
| Application Number: | 15/519,676 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,188,652
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | DAYVIGO | lemborexant | TABLET;ORAL | 212028-001 | Apr 7, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF ADULT PATIENTS WITH INSOMNIA, CHARACTERIZED BY DIFFICULTIES WITH SLEEP ONSET AND/OR SLEEP MAINTENANCE | ⤷ Try a Trial | |||
| Eisai Inc | DAYVIGO | lemborexant | TABLET;ORAL | 212028-002 | Apr 7, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF ADULT PATIENTS WITH INSOMNIA, CHARACTERIZED BY DIFFICULTIES WITH SLEEP ONSET AND/OR SLEEP MAINTENANCE | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,188,652
| PCT Information | |||
| PCT Filed | October 21, 2015 | PCT Application Number: | PCT/JP2015/080304 |
| PCT Publication Date: | April 28, 2016 | PCT Publication Number: | WO2016/063995 |
International Family Members for US Patent 10,188,652
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015336463 | ⤷ Try a Trial | |||
| Brazil | 112017007063 | ⤷ Try a Trial | |||
| Canada | 2964504 | ⤷ Try a Trial | |||
| China | 107810006 | ⤷ Try a Trial | |||
| European Patent Office | 3209298 | ⤷ Try a Trial | |||
| Spain | 2843952 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
